Aspirin and Dipyridamole Capsules and Ranibizumab Intraocular
Determining the interaction of Aspirin and Dipyridamole Capsules and Ranibizumab Intraocular and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: aspirin / dipyridamole
Brand name: Aggrenox
Synonyms: Aspirin and dipyridamole, Aspirin and Dipyridamole
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Aspirin and Dipyridamole Capsules-Ranibizumab ophthalmic
- Aspirin and Dipyridamole Capsules-Ranitidine
- Aspirin and Dipyridamole Capsules-Ranitidine Capsule
- Aspirin and Dipyridamole Capsules-Ranitidine Hydrochloride
- Aspirin and Dipyridamole Capsules-Ranitidine Injection
- Aspirin and Dipyridamole Capsules-Ranitidine Suspension
- Ranibizumab Intraocular-Aspirin and omeprazole
- Ranibizumab Intraocular-Aspirin and Omeprazole Tablets
- Ranibizumab Intraocular-Aspirin and oxycodone
- Ranibizumab Intraocular-Aspirin Chewable Tablets
- Ranibizumab Intraocular-Aspirin Enteric-Coated and Buffered Tablets
- Ranibizumab Intraocular-Aspirin Extended-Release Capsules